Similar articles

• A study of the effects of ranolazine using automated quantitative analysis of serial myocardial perfusion images.

  Venkataraman R, Belardinelli L, Blackburn B, Heo J, Iskandrian AE. Venkataraman R, et al. JACC Cardiovasc Imaging. 2009 Nov;2(11):1301-9. doi: 10.1016/j.jcmg.2009.09.006. JACC Cardiovasc Imaging. 2009. PMID: 19909934 Clinical Trial.
• Ranolazine improves angina in women with evidence of myocardial ischemia but no obstructive coronary artery disease.

  Mehta PK, Goykhman P, Thomson LE, Shufelt C, Wei J, Yang Y, Gill E, Minissian M, Shaw LJ, Slomka PJ, Slivka M, Berman DS, Bairey Merz CN. Mehta PK, et al. JACC Cardiovasc Imaging. 2011 May;4(5):514-22. doi: 10.1016/j.jcmg.2011.03.007. JACC Cardiovasc Imaging. 2011. PMID: 21565740 Free PMC article. Clinical Trial.
• [Late sodium current and calcium overload--pathogenesis and adequate treatment].

  Jacobshagen C. Jacobshagen C. Dtsch Med Wochenschr. 2013 Apr;138(16):842-7. doi: 10.1055/s-0033-1343117. Epub 2013 Apr 15. Dtsch Med Wochenschr. 2013. PMID: 23589047 Review. German. No abstract available.
• Ranolazine in patients with angina and coronary artery disease.

  Scirica BM, Morrow DA. Scirica BM, et al. Curr Cardiol Rep. 2007 Jul;9(4):272-8. doi: 10.1007/BF02938375. Curr Cardiol Rep. 2007. PMID: 17601393 Review.
• Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic Function.

  Shah NR, Cheezum MK, Veeranna V, Horgan SJ, Taqueti VR, Murthy VL, Foster C, Hainer J, Daniels KM, Rivero J, Shah AM, Stone PH, Morrow DA, Steigner ML, Dorbala S, Blankstein R, Di Carli MF. Shah NR, et al. J Am Heart Assoc. 2017 May 4;6(5):e005027. doi: 10.1161/JAHA.116.005027. J Am Heart Assoc. 2017. PMID: 28473401 Free PMC article. Clinical Trial.